Speaker
Scientist, Ajinomoto Co., Inc.
Tomohiro Watanabe, Scientist at Ajinomoto Co., Inc., spoke at 17th World ADC San Diego (San Diego, United States of America, 12–15 Oct 2026) in the session “Unlocking Next-Generation Antibody-Based Conjugates through AJICAP Site-Specific Conjugation & Linker Technologies”.
12–15 Oct 2026San Diego, United States of America
Chief Scientific Officer, Iksuda Therapeutics
Associate Director, Medicinal Chemistry, AstraZeneca
Senior Director, Chemistry, Sutro Biopharma
Chief Scientific Officer, Callio Therapeutics
President & Founder, Bramhill Biologics Consulting
Executive Director, Product Stewardship Lead, AstraZeneca
These are kept as separate profiles because the programmes give no evidence that they are the same person.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Tomohiro Watanabe, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].